Medical News Feed
German Drug Data (Deutsch)
Norwegian Drug Data (Norge)
Netherlands Drug Data (Nederlands)
Swedish Drug Data (Sverige)
Want to submit or suggest content for the epgonline.org YouTube Clinical channel?
Contact us here
epgonline.org is not responsible for content on any 3rd party website
Please register to access disease diagnosis, patient management, physician tools.
By viewing the content of this web page you are both confirming your status as a healthcare professional and agreeing to our terms of use.
| Drug class description : | Local anaesthetics / corticosteroids (steroids). |
| Generic Name : | Lidocaine [lignocaine], hydrocortisone acetate |
| Drug description : | Ointment. |
| Presentation : | Ointment, lidocaine 5%, hydrocortisone acetate 0.275%. |
| Indications : | For the relief of symptoms such as anal and peri-anal pruritus, pain and inflammation associated with haemorrhoids, anal fissure, fistulas and proctitis. Pruritus vulva. |
| Adult Dosage : | To be applied several times daily according to the severity of the condition. A daily dose of 6 g ointment is well within safety limits. The duration of treatment may vary between 10 days and three weeks. |
| Contra Indications : | Known hypersensitivity to local anaesthetics of the amide type or any of the other ingredients. Use on atrophic skin. |
| Special Precautions : | Avoid prolonged use. Pregnancy. Exclude possibility of malignancy before use. Discontinue use if irritation or rectal bleeding irritation or rectal bleeding develops. Antibacterial, antiviral or antifungal therapy should be given with Xyloproct if infection is present at the site of application. |
| Interactions : | Lidocaine should be used with caution in patients receiving antiarrhythmic drugs since toxic effects are additive. |
| Adverse Reactions : | Contact sensitivity to lidocaine has been reported after perianal use. Contact sensitivity may also occur after the use of topical hydrocortisone. In extremely rare cases amide-type local anaesthetic preparations have been associated with allergic reactions (in the most severe instances anaphylactic shock). |
| Manufacturer : | AstraZeneca |
| Drug Availability : | (POM) |
Only registered users have access to the full EPG Online Knowledge Base including drug search tools, interactive disease Knowledge Centres via the EPG Knowledge Library - with clinical and evidence based physician and research tools, MiMedia (build your own clinical media collection with everything from key opinion leader essays to mode of action videos and other multi-media content), the EPG Survey panel, health news updates and much much more.
Already Registered?
Please log-in now using our member login box.
Not a member?
Don't worry, registration is quick and FREE! We welcome all Healthcare professionals, doctors, nurses and medical students.
Register today to have full access to a wealth of drug data, educational and evidence based interactive guides across all major therapeutic areas, disease management, and clinical tools.
As a practicing Healthcare professional, you can also opt-in to join our market research panel – www.epgsurvey.com – and get paid for sharing your expert clinical opinions!
REGISTER today it only takes a minute! and it's FREE
Having problems?
Use our forgotten password facility or email us at: contact@epgonline.org